Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Appointed director
Director comp.
Acq. announced
Director departure
|
|
RHYTHM PHARMACEUTICALS, INC. (RYTM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
4/A
| Cramer Pamela J. (Chief Human Resources Officer) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 843 shares
@ $27.51, valued at
$23.2k
|
|
| 02/14/2023 |
4/A
| Mazabraud Yann (EVP, Head of International) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 1,563 shares
@ $27.51, valued at
$43k
|
|
| 02/14/2023 |
4/A
| Roberts William T. (Chief Accounting Officer) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 969 shares
@ $27.51, valued at
$26.7k
|
|
| 02/14/2023 |
4/A
| Shulman Joseph (Chief Technical Officer) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 931 shares
@ $27.51, valued at
$25.6k
|
|
| 02/14/2023 |
4/A
| Chien Jennifer (EVP, Head of North America) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 1,204 shares
@ $27.51, valued at
$33.1k
|
|
| 02/14/2023 |
4/A
| Smith Hunter C (CFO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 1,413 shares
@ $27.51, valued at
$38.9k
|
|
| 06/16/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
|
|